MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...

Shares of aerospace and defense company HEICO (NSYE:HEI) jumped 4.1% in the morning session after the company reported strong third-quarter results that surpassed analyst expectations for both revenue ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› Using your dryer’s unheated ...

We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› by Anna Wenner Denture ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...

Todd Vande Hei, host of the Health Is a Skill podcast, recently welcomed Dr. Alice Nguyen, a naturopathic doctor, movement advocate, and educator, to share her strategies for long-term vitality and ...

Funds managed by Blue Owl Capital, the New York-based alternative asset manager, has made a $2.5 billion investment in Point, a leading home equity investment (HEI) platform, to help the latter expand ...

HEI announced a cash dividend of 0.12 with an ex-date of Jan. 5, 2026 Chart does not reflect overnight price.

Abstract: The mechanical properties of the Ti-6Al-4V alloy make it a promising material for high-temperature applications. However, uncertainties surround the long-term performance and reliability of ...